Vantage Consulting Group’s Medpace MEDP Stock Holding History

Vantage Consulting Group’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-62	Closed	-$9K	–	960
2020 Q4	$9K	Buy	+62	New	+$7.81K	﹤0.01%	1257

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vantage Consulting Group's MEDP Position: Q1 2021 in Review

Vantage Consulting Group sold out of Medpace (MEDP) in Q1 2021, closing a stake of 62 shares — an estimated $9K sold.

Vantage Consulting Group first reported a position in MEDP in Q4 2020 and held it in 1 quarter. The position peaked at $9K in Q4 2020. 319 funds tracked by Wall St. Rank hold MEDP as of Q1 2021.

Vantage Consulting Group reported no remaining Medpace position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 62 Medpace shares in Q1 2021, an estimated $9K.
Vantage Consulting Group first reported a position in Medpace in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's Medpace position peaked at $9K in Q4 2020.
319 funds tracked by Wall St. Rank held Medpace as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.